Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase

• Published in: PloS one Vol. 17; no. 12; p. e0278713
• Main Authors: Katz, Michael, Diskin, Ron
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 13.12.2022; Public Library of Science (PLoS)
• Subjects: Analysis; Biology and Life Sciences; Chromatography; Crystallography; Crystallography, X-Ray; Cytoskeleton; Dimers; Domains; Electrostatic properties; Enzymes; Extracellular matrix; Extracellular Matrix - metabolism; Glucosamine; Glycosylation; Glycosyltransferase; Glycosyltransferases - metabolism; Golgi apparatus; Kinases; Mathematical analysis; Monomers; Muscles; Mutation; Oligomerization; Physical Sciences; Polymers; Polysaccharides; Properties; Protein Domains; Proteins; Research and Analysis Methods; Substrates; Synthesis; X-ray crystallography; Israel
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0278713

LARGE1 is a bifunctional glycosyltransferase responsible for generating a long linear polysaccharide termed matriglycan that links the cytoskeleton and the extracellular matrix and is required for proper muscle function. This matriglycan polymer is made with an alternating pattern of xylose and glucuronic acid monomers. Mutations in the LARGE1 gene have been shown to cause life-threatening dystroglycanopathies through the inhibition of matriglycan synthesis. Despite its major role in muscle maintenance, the structure of the LARGE1 enzyme and how it assembles in the Golgi are unknown. Here we present the structure of LARGE1, obtained by a combination of X-ray crystallography and single-particle cryo-EM. We found that LARGE1 homo-dimerizes in a configuration that is dictated by its coiled-coil stem domain. The structure shows that this enzyme has two canonical GT-A folds within each of its catalytic domains. In the context of its dimeric structure, the two types of catalytic domains are brought into close proximity from opposing monomers to allow efficient shuttling of the substrates between the two domains. Together, with putative retention of matriglycan by electrostatic interactions, this dimeric organization offers a possible mechanism for the ability of LARGE1 to synthesize long matriglycan chains. The structural information further reveals the mechanisms in which disease-causing mutations disrupt the activity of LARGE1. Collectively, these data shed light on how matriglycan is synthesized alongside the functional significance of glycosyltransferase oligomerization.